Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1

Clinical Endocrinology

Volumn 55, Issue 5, 2001, Pages 689-693

  Burgess, John R ^a   Giles, Natalie ^b   Shepherd, Joseph J ^c  

^a ROYAL HOBART HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER PREVENTION; CARCINOID; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; ENDOCRINE TUMOR; HISTOPATHOLOGY; HUMAN; MALE; PARATHYROIDECTOMY; PRIORITY JOURNAL; RELIABILITY; STERNOTOMY; THYMECTOMY; THYMOMA; TREATMENT OUTCOME; TUMOR BIOPSY;

ADOLESCENT; CARCINOID TUMOR; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; OCTREOTIDE; PARATHYROIDECTOMY; THYMECTOMY; THYMUS NEOPLASMS; TREATMENT FAILURE;

EID: 0035723553     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01348.x     Document Type: Article

References (8)

1. Multiple endocrine neoplasia type 1 (MEN 1) - Current concepts in diagnosis and management
2. Clinical management of the multiple endocrine neoplasia syndromes: Results of a computerised opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease
3. Multiple endocrine neoplasia type 1: Clinical and genetic topics
4. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1
5. Thymic carcinoids in multiple endocrine neoplasia type 1
6. Cause of death in multiple endocrine neoplasia type 1
7. Multiple endocrine neoplasia type 1